Ocimum Biosolutions’ Biotracker software application has achieved GeneChip-compatible status with the Affymetrix Inc GeneChip microarray platform and has agreed to participate in the Affymetrix GeneChip-compatible Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development.
Ocimum's Biotracker is a GLP and US FDA 21 CFR Part 11 compliant Laboratory Information and Knowledge Management System. It is a tool for improving laboratory performance which allows analysts to keep track of samples, reagents, instruments, processes, and results at every stage of a project.
Biotracker is a customized LIMS solution which has various modules, some of which are-Laboratory Administration module, Resource Schedule module, Project Tracking, Analysis and Result Archival module, Inventory Management and Tracking System module, Sample Tracking module & Plate tracking module.
“We are very happy to be part of the GeneChip-compatible Applications Program with the market leader in the microarray space. Biotracker is a very flexible and configurable program and we understand the Affymetrix platform performs well to provide users with customized solutions,” said Anuradha Acharya, CEO, Ocimum Biosolutions.
“Many of our customers are now applying microarray methods initially developed for basic research into translational medicine and clinical research,” said Steve Lincoln, vice president of Informatics at Affymetrix.
Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas—BioIT, Microarrays and contract research services. The Microarray division of Ocimum has been recently acquired from MWG Biotech. These include Catalog OciChips, Custom OciChips and Hybridization services.
Affymetrix GeneChip technology is used by the pharmaceutical, diagnostic and biotechnology companies as well as academic, government and not-for-profit research institutes. Headquartered in Santa Clara, California, Affymetrix has subsidiaries in Europe and Asia.